No agreement imminent on salmon labeling

FDA public hearing focuses on differences over who should alert consumers that a salmon is genetically altered.Beyond sharp and predictable differences over whether genetically engineered salmon belongs in the food supply, a rough consensus emerged Tuesday at a Food and Drug Administration hearing on labeling requirements: If the fish is approved for market, consumers should have a way to avoid it.

Read the whole article on LA Times - Science

More from LA Times - Science